Bank Of America Corp Solid Biosciences Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.51 - $7.56 $7,815 - $115,857	-15,325 Reduced 30.46%	34,990 $17,000
Q2 2022 Aug 12, 2022	SELL	$0.43 - $1.24 $801 - $2,310	-1,863 Reduced 3.57%	50,315 $31,000
Q1 2022 May 16, 2022	SELL	$0.74 - $1.79 $11,090 - $26,826	-14,987 Reduced 22.31%	52,178 $63,000
Q4 2021 Feb 08, 2022	SELL	$1.69 - $2.46 $98,351 - $143,162	-58,196 Reduced 46.42%	67,165 $118,000
Q3 2021 Nov 15, 2021	BUY	$2.38 - $3.77 $184,649 - $292,491	77,584 Added 162.39%	125,361 $299,000
Q2 2021 Sep 13, 2021	BUY	$3.49 - $5.51 $166,741 - $263,251	47,777 New	47,777 $175,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $22.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.